Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.

Saved in:
Bibliographic Details
Title: Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.
Authors: Beelen DW; Department of Bone Marrow Transplantation, West German Cancer Center, University of Duisburg-Essen, Duisburg, Germany., Arnold R; Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Stelljes M; Department of Medicine/Hematology and Oncology, University of Muenster, Münster, Germany., Alakel N; Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany., Brecht A; Helios Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany., Bug G; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany., Bunjes D; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Faul C; Department of Hematology and Oncology, Tuebingen University Hospital, Tübingen, Germany., Finke J; Department of Hematology, Oncology and Stem-Cell Transplantation, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg im Breisgau, Germany., Franke GN; Division of Haematology & Oncology, University Hospital Leipzig, Leipzig, Germany., Holler E; Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany., Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany., Kröger N; Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Rösler W; Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany., Scheid C; Department I of Internal Medicine, Center of Integrated Oncology Cologne, Cologne, Germany., Schönland S; Department Medicine V, University of Heidelberg, Heidelberg, Germany., Stadler M; Hematology & Oncology, Medical Center University of Hannover, Hannover, Germany., Tischer J; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Wagner-Drouet E; Department of Hematology, Medical Oncology and Pneumology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Wendelin K; Department of Internal Medicine 5, Klinikum Nürnberg, Paracelsus Medizinische Privatuniversität, Nürnberg, Germany., Brüggemann M; Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany., Reiser L; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany., Hoelzer D; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany., Gökbuget N; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany. Electronic address: goekbuget@em.uni-frankfurt.de.
Source: Transplantation and cellular therapy [Transplant Cell Ther] 2022 Dec; Vol. 28 (12), pp. 834-842. Date of Electronic Publication: 2022 Aug 27.
Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-6367
DOI:10.1016/j.jtct.2022.08.024